Literature DB >> 4851289

Delta-9-tetrahydrocannabinol and glucose tolerance.

L E Hollister, G M Reaven.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4851289     DOI： 10.1002/cpt1974162297

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN： 0009-9236            Impact factor:   6.875


× No keyword cloud information.
  15 in total

1.  Some cannabinoid receptor ligands and their distomers are direct-acting openers of SUR1 K(ATP) channels.

Authors:  Christopher J Lynch; Qing Zhou; Show-Ling Shyng; David J Heal; Sharon C Cheetham; Keith Dickinson; Peter Gregory; Michael Firnges; Ulrich Nordheim; Stephanie Goshorn; Dania Reiche; Lechoslaw Turski; Jochen Antel
Journal:  Am J Physiol Endocrinol Metab       Date:  2011-12-13       Impact factor: 4.310

2.  Hepatic cannabinoid receptor-1 mediates diet-induced insulin resistance via inhibition of insulin signaling and clearance in mice.

Authors:  Jie Liu; Liang Zhou; Keming Xiong; Grzegorz Godlewski; Bani Mukhopadhyay; Joseph Tam; Shi Yin; Peter Gao; Xin Shan; James Pickel; Ramon Bataller; James O'Hare; Thomas Scherer; Christoph Buettner; George Kunos
Journal:  Gastroenterology       Date:  2012-01-31       Impact factor: 22.682

Review 3.  Endocannabinoids in liver disease.

Authors:  Joseph Tam; Jie Liu; Bani Mukhopadhyay; Resat Cinar; Grzegorz Godlewski; George Kunos
Journal:  Hepatology       Date:  2011-01       Impact factor: 17.425

Review 4.  Cardiovascular effects of marijuana and synthetic cannabinoids: the good, the bad, and the ugly.

Authors:  Pal Pacher; Sabine Steffens; György Haskó; Thomas H Schindler; George Kunos
Journal:  Nat Rev Cardiol       Date:  2017-09-14       Impact factor: 32.419

5.  Hepatic CB1 receptor is required for development of diet-induced steatosis, dyslipidemia, and insulin and leptin resistance in mice.

Authors:  Douglas Osei-Hyiaman; Jie Liu; Liang Zhou; Grzegorz Godlewski; Judith Harvey-White; Won-il Jeong; Sándor Bátkai; Giovanni Marsicano; Beat Lutz; Christoph Buettner; George Kunos
Journal:  J Clin Invest       Date:  2008-09       Impact factor: 14.808

Review 6.  Endocannabinoids and the control of energy homeostasis.

Authors:  George Kunos; Douglas Osei-Hyiaman; Jie Liu; Gregorz Godlewski; Sándor Bátkai
Journal:  J Biol Chem       Date:  2008-08-11       Impact factor: 5.157

7.  Monounsaturated fatty acids generated via stearoyl CoA desaturase-1 are endogenous inhibitors of fatty acid amide hydrolase.

Authors:  Jie Liu; Resat Cinar; Keming Xiong; Grzegorz Godlewski; Tony Jourdan; Yuhong Lin; James M Ntambi; George Kunos
Journal:  Proc Natl Acad Sci U S A       Date:  2013-11-04       Impact factor: 11.205

Review 8.  Modulating the endocannabinoid system in human health and disease--successes and failures.

Authors:  Pál Pacher; George Kunos
Journal:  FEBS J       Date:  2013-04-22       Impact factor: 5.542

Review 9.  Endocannabinoid regulation of β-cell functions: implications for glycaemic control and diabetes.

Authors:  T Jourdan; G Godlewski; G Kunos
Journal:  Diabetes Obes Metab       Date:  2016-03-31       Impact factor: 6.577

10.  Metabolic effects of chronic cannabis smoking.

Authors:  Ranganath Muniyappa; Sara Sable; Ronald Ouwerkerk; Andrea Mari; Ahmed M Gharib; Mary Walter; Amber Courville; Gail Hall; Kong Y Chen; Nora D Volkow; George Kunos; Marilyn A Huestis; Monica C Skarulis
Journal:  Diabetes Care       Date:  2013-03-25       Impact factor: 19.112
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.